当前位置:
X-MOL 学术
›
Nat. Rev. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Management of IBD during the COVID-19 outbreak: resetting clinical priorities.
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2020-05-01 , DOI: 10.1038/s41575-020-0294-8 Silvio Danese 1, 2 , Maurizio Cecconi 2, 3 , Antonino Spinelli 2, 4
Nature Reviews Gastroenterology & Hepatology ( IF 45.9 ) Pub Date : 2020-05-01 , DOI: 10.1038/s41575-020-0294-8 Silvio Danese 1, 2 , Maurizio Cecconi 2, 3 , Antonino Spinelli 2, 4
Affiliation
The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities.
中文翻译:
COVID-19 爆发期间 IBD 的管理:重置临床优先事项。
冠状病毒病 (COVID-19) 的全球爆发给包括炎症性肠病 (IBD) 中心在内的所有医疗保健系统带来了巨大挑战。在这里,我们描述了 IBD 专家在这次 SARS-CoV-2 感染大流行期间可能面临的快速变化和临床问题,强调了潜在的护理重新安排和临床优先事项的重新设置。
更新日期:2020-03-25
中文翻译:
COVID-19 爆发期间 IBD 的管理:重置临床优先事项。
冠状病毒病 (COVID-19) 的全球爆发给包括炎症性肠病 (IBD) 中心在内的所有医疗保健系统带来了巨大挑战。在这里,我们描述了 IBD 专家在这次 SARS-CoV-2 感染大流行期间可能面临的快速变化和临床问题,强调了潜在的护理重新安排和临床优先事项的重新设置。